HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Cancer screening recommendations must change as knowledge grows
-
- American Thyroid Association: Better communication among care team critical for optimal care, surveillance
- Approval of treatments for Hodgkin’s lymphoma, myelofibrosis, prostate cancer among highlights of 2011 Joseph R. Bertino, MD; Harry S. Jacob, MD, DHC
- ATM gene may increase risk for pancreatic ductal adenocarcinoma
- Cognitive functioning affected by chemotherapy
- Despite reduced malignant ascites in ovarian cancer, aflibercept should be used with caution
- Follicular lymphoma vaccine specifically targets tumor cells, offers individualized treatment
- Gene mutation may explain chemoresistance in colon cancer
- Lymph node dissection should be part of regular thyroid cancer surgery
-
- Novel classes of drugs identified with antiproliferative effect in thyroid cancer
- Oncologists are patients' preferred providers of follow-up care
- Patterns indicated great variation in use of accelerated partial breast irradiation with brachytherapy
- Physicians, patients disagree about shared access to medical records
- Radiation safe in Merkel cell carcinoma; resulted in low local regional failure
- Radiation therapy for left-sided breast cancer linked to elevated heart risk
- Salvage surgery for nasopharyngeal carcinoma resulted in good QOL
- Yoga improved fatigue, vigor in breast cancer survivors
-
- FDA proposes draft guidelines intended to improve representation of women in clinical studies
- An evolving view of acute leukemia William Wood, MD
- Brian I. Rini, MD: Wine enthusiast, musician, triathlete and leader in genitourinary cancer care
- Accelerated partial-breast brachytherapy linked to more toxicity than whole-breast irradiation
- Additional catheter-directed thrombolysis benefited patients with DVT
- Alternating TKIs in CML treatment had similar response rates to single TKI treatment
- Genetically engineered T cells target lymphomas, leukemias that express CD19
- IIS levels affect life cycle of VSELs in adult tissues
-
- IOM identifies factors that may increase breast cancer risk
- MRI measures may predict breast cancer prognosis
- Nilotinib shows promise as first-line therapy in CML
- Radiation linked to poor long-term OS among HL patients
- Researchers develop possible platelet production system
- Survival improved in HER-2–positive breast cancer patients treated with drug combination
- Triple combination therapy triggered systemic antitumor response in metastatic lymphoma
- Brentuximab vedotin: A breakthrough for refractory CD30+ lymphomas Sarah Rodriguez, PharmD, BCPS
-